Owc Pharmaceutical Research Stock Earnings Per Share
OWCP Stock | USD 0.0001 0.00 0.00% |
OWC Pharmaceutical Research fundamentals help investors to digest information that contributes to OWC Pharmaceutical's financial success or failures. It also enables traders to predict the movement of OWC Pink Sheet. The fundamental analysis module provides a way to measure OWC Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OWC Pharmaceutical pink sheet.
OWC |
OWC Pharmaceutical Research Company Earnings Per Share Analysis
OWC Pharmaceutical's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current OWC Pharmaceutical Earnings Per Share | (0.01) X |
Most of OWC Pharmaceutical's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OWC Pharmaceutical Research is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition |
According to the company disclosure, OWC Pharmaceutical Research has an Earnings Per Share of -0.012 times. This is 100.14% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The earnings per share for all United States stocks is 100.38% higher than that of the company.
OWC Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OWC Pharmaceutical's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of OWC Pharmaceutical could also be used in its relative valuation, which is a method of valuing OWC Pharmaceutical by comparing valuation metrics of similar companies.OWC Pharmaceutical is currently under evaluation in earnings per share category among related companies.
OWC Fundamentals
Return On Asset | -0.64 | |||
Current Valuation | 49.75 K | |||
Shares Outstanding | 497.5 M | |||
Shares Owned By Insiders | 11.15 % | |||
Price To Earning | (12.76) X | |||
Price To Book | 42.29 X | |||
EBITDA | (10.25 M) | |||
Net Income | (10.26 M) | |||
Cash And Equivalents | 1.47 M | |||
Cash Per Share | 0.01 X | |||
Debt To Equity | 0.15 % | |||
Current Ratio | 3.12 X | |||
Book Value Per Share | (0.02) X | |||
Cash Flow From Operations | (2.5 M) | |||
Earnings Per Share | (0.01) X | |||
Beta | -224.47 | |||
Market Capitalization | 49.75 K | |||
Total Asset | 3.55 M | |||
Retained Earnings | (25.14 M) | |||
Working Capital | (75 K) | |||
Current Asset | 112 K | |||
Current Liabilities | 187 K | |||
Z Score | -16.4 | |||
Net Asset | 3.55 M |
About OWC Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OWC Pharmaceutical Research's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OWC Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OWC Pharmaceutical Research based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OWC Pharmaceutical Research. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the OWC Pharmaceutical information on this page should be used as a complementary analysis to other OWC Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for OWC Pink Sheet analysis
When running OWC Pharmaceutical's price analysis, check to measure OWC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OWC Pharmaceutical is operating at the current time. Most of OWC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of OWC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OWC Pharmaceutical's price. Additionally, you may evaluate how the addition of OWC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |